TOXINS AND ANTITOXINS 299 



Cooper, G., Edwards, M., and Rosenstein, C: The Separation of Types 

 Among the Pneumococci Hitherto Called Group IV and the Develop- 

 ment of Therapeutic Antiserums From These Types, J. Exper. Med. 

 49: 461, 1929. 



Cooper, G., Rosenstein, C, Walter, A., and Peizer. L. : Tlie Further Separa- 

 tion of Types Among the Pneumococci Hitherto Included in Group 

 IV and the Development of Therapeutic Antisera for These Types, 

 J. Exper. Med. 55: 531, 1932. 



Dick, G. F., and Dick, G. H.: Therapeutic Results "With Concentrated 

 Scarlet Fever Antitoxin: Preparation, Standardization and Dosage 

 of Antitoxin, J. A. M. A. 84: 803, 1925. Scarlet Fever Antitoxin, 

 Ibid. 82: 1246, 1924. 



Dick, G. F., and Dick, G. H.: (1939) Cited bv Zinsser and Bavne-Jones, p. 

 297. 



Dick, G. F., and Dick, G. H.: Experimental Scarlet Fever, J. A. M. A. 81: 

 1166, 1923. The Etiology of Scarlet Fever, Ibid. 82: 301, 1924. 



Dick, G. F., and Dick, G. H.: A Skin Test for Susceptibility to Scarlet 

 Fever, J. A. M. A. 82: 265, 1924. 



Dochez, A. R.: Etiology of Scarlet Fever, Medicine 4: 251, 1925. 



Dochez, A. R., and Gillespie, L. J.: A Biologic Classification of Pneumo- 

 cocci by Means of Immunity Reactions, J. A. M. A. 61: 727, 1913. 



Downs, C. M., and Stookey, P.: Some Observations Concerning Erythem- 

 atous Eruptions Simulating Scarlet Fever Developing in the Puer- 

 perium, Am. .T. ()]>st. & (iynec. 23: 735, 1932. 



Dubos, R. .1. : The Effect of Specific Agents Extracted From Soil Microorgan- 

 isms Upon Experimental Bacterial Infections, Ann. Int. Med. 13: 2025, 

 1940. 



Dulitskiy, S. O. : Prophylaxis of Measles by Means of Serum of Adults and 

 of Placental Serum, Jurnal P. Rannemu Detskomu Vozrastu, Moscow 

 12: 317, 1932. Abstract in J. A. M. A. 100: 1733, 1933. 



Duryea, A.: Reaction to Antimeningococcus Serum, J. A. M. A. 95: 1582, 

 1930. 



Eberson, F. : Experimental Study of an Antipoliomyelitic Serum From 

 Monkeys Artificially Immunized With an Organism Cultivated From 

 Poliomvelitis Nervous Tissue, J. Immunol. 24: 433, 1933. 



Editorial: Serum Therapy in Poliomyelitis, J. A. M. A. 103: 262, 1934. 



Editorial: A Poliomyelitis Vaccine, J. A. M. A. 103: 264, 1934. 



Editorial: The Hemolytic Streptococci in Rheumatism, J. A. M. A. 100: 

 260, 1933. 



Editorial: Active Immunization With Tetanus Toxoid, J. A. M. A. 101: 

 934, 1933. 



Editorial: Refined Antipneumococcus Serum, J. A. M. A. 96: 1505, 1931. 



Falk, G. K., McGuire, G., and Rosenstein, C: Studies on Antibodies. Yl. 

 Dried Antimeningococcus Serums, J. Immunol. 22: 445, 1932. 



Felton, L. D. : Dissociation of the Specific Proteins Precipitate of Anti- 

 pneumococcus Horse Serum, and a Comparison With a Protein Isolated 

 bv Chemical Means From This Immune Serum, J. Immunol. 22: 453. 

 1932. 



Felton, L. D., and Kauffman, G.: The Lipoidal Content of Antipneumococcic 

 Horse Serum, J. Immunol. 24: 543, 1933. 



Felton, L. D.: Pneumococcus Antibodies — ^What Are They? Science 79: 

 277, 1934. 



Ferry, Newell S.: Meningococcus Antitoxin. I. Prophylactic and Thera- 

 peutic Tests on Guinea Pigs,* J. Immunol. 23: 315, 1932. 



Ferry, Newell S.: ileningococcus Antitoxin. II. Therapeutic Tests on 

 Monkeys, J. Immunol. 23: 325, 1932. 



Ferry, Newell S.: Meningococcus Toxin and Antitoxin. III. Further Tests 

 on Monkeys, J. Immunol. 26: 133, 1934. 



